Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
December 09, 2025 21:42 ET Â | Source: Dyne Therapeutics, Inc. WALTHAM, Mass.,…
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16…
Built for Better: Srixons New ZXiR Irons Redefine Game Improvement
HUNTINGTON BEACH, Calif., Dec. 4, 2025 – Expanding its acclaimed ZXi Iron…
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and…
Varvee Global Limited (VGL) Posts Strong Operational Profit & EBDITA for Q2FY26: +80% Revenue Growth, 49.8% EBITDA Margin; PAT +23.5% YoY; H1 PAT +15.7% and Attaining Near-Zero Debt
AHMEDABAD, India, Nov. 13, 2025 /PRNewswire/ -- VGL Limited ("VGL" or the…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Innoviti Posts 35% Revenue Growth in FY25
Strong execution across all product lines led to gross margin improvement by…
Volvo Trucks: Advancing Road Safety Across Southeast Asia
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
Urban Company Limited Launches ‘Revamp’: Transform Any Wall, Any Space in a Day
MUMBAI, India, Aug. 27, 2025 /PRNewswire/ --Â Urban Company Limited today announced the…